CUSP Advances in Genetic Editing with CRISPR Technology
Offering new prospects for medical inventions, Chapman University School of Pharmacy researchers continue to make strides in gene editing. The recent study “Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery” centers around the manipulation of genetic material through the CRISPR technology, a technology that has regained momentum since initial reports in 2005. The authors, including faculty